Tirzepatide : Approved for type 2 diabetes management (Mounjaro) but widely prescribed off-label for weight loss
GLP-1 is a hormone found in a class of injectable drug products (GLP-1 drugs) which lower serum glucose levels and thereby manage metabolism for patients with diabetes and obesity disorders
Mounjaro, and other weight loss injections, like Ozempic and Wegovy, are similar
Increased serum levels of human pancreatic polypeptide (HPP), gastrin, motilin, CCK, PYY, ghrelin, and also GIP, GLP-1, and GLP-2 have been reported either at baseline or postprandially in UC and/or CD (154, 163, 165168)
There was a significant difference in the baseline BMI between the two groups, with the acetazolamide group having a mean BMI of 32, compared with 38 in the GLP-1 agonist group
How does Retatrutide compare to Semaglutide and Tirzepatide